Oral contraceptive use and risk of vulvodynia: a population‐based longitudinal study

To assess whether the risk of vulvodynia is associated with previous use of oral contraceptives (OCs).

[1]  Ananda Sen,et al.  Prevalence and demographic characteristics of vulvodynia in a population-based sample. , 2012, American journal of obstetrics and gynecology.

[2]  C. Battaglia,et al.  Sexual behavior and oral contraception: a pilot study. , 2012, The journal of sexual medicine.

[3]  S. Caruso,et al.  Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol. , 2011, The journal of sexual medicine.

[4]  D. Erickson,et al.  Self-reported vulvar pain characteristics and their association with clinically confirmed vestibulodynia. , 2009, Journal of women's health.

[5]  B. Reed,et al.  Vulvodynia in Preadolescent Girls , 2008, Journal of lower genital tract disease.

[6]  G. Bachmann,et al.  Assessment of vulvodynia symptoms in a sample of U.S. women: a follow-up national incidence survey. , 2008, Journal of women's health.

[7]  Ananda Sen,et al.  Vulvodynia Incidence and Remission Rates Among Adult Women: A 2-Year Follow-up Study , 2008, Obstetrics and gynecology.

[8]  A. Vitonis,et al.  Influence of oral contraceptive use on the risk of adult-onset vulvodynia. , 2008, The Journal of reproductive medicine.

[9]  Ananda Sen,et al.  Effect of test order on sensitivity in vulvodynia. , 2007, Journal of reproductive medicine.

[10]  Ananda Sen,et al.  Reliability and Validity of Self-Reported Symptoms for Predicting Vulvodynia , 2006, Obstetrics and gynecology.

[11]  N. Avis,et al.  Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey. , 2006, The Journal of reproductive medicine.

[12]  S. Caruso,et al.  Sexual behavior of women taking low-dose oral contraceptive containing 15 μg ethinylestradiol/60 μg gestodene , 2004 .

[13]  S. Caruso,et al.  Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. , 2004, Contraception.

[14]  H. Stenlund,et al.  Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study , 2003, Scandinavian journal of public health.

[15]  B. Harlow,et al.  A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? , 2003, Journal of the American Medical Women's Association.

[16]  E. Rylander,et al.  Vulvar pain, sexual behavior and genital infections in a young population: a pilot study , 2002, Acta obstetricia et gynecologica Scandinavica.

[17]  J. Brisson,et al.  Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. , 2002, American journal of epidemiology.

[18]  D. Hellberg,et al.  Vaginal microbiological flora, and behavioural and clinical findings in women with vulvar pain , 2001, BJOG : an international journal of obstetrics and gynaecology.

[19]  E. Barrett-Connor,et al.  Estrogen, apolipoprotein E, and dementia. , 1997, Journal of women's health.

[20]  I. Sjöberg,et al.  Vulvar vestibulitis in the north of Sweden. An epidemiologic case-control study. , 1997, The Journal of reproductive medicine.

[21]  J. Woodruff,et al.  Case-Control Study of Vulvar Vestibulitis Syndrome , 1995 .

[22]  J. Brisson,et al.  Vulvar Vestibulitis Syndrome: An Exploratory Case-Control Study , 1994, Obstetrics and gynecology.